sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Liposome Drug Delivery Market Scope And Analysis

  • Report Code : TIPRE00014203
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 138
Buy Now

North America Liposome Drug Delivery Market Scope, Analysis, and Trends by 2027

Buy Now

North America Liposome Drug Delivery Market Report North America Liposome Drug Delivery Market Size and Share North America Liposome Drug Delivery Market Scope and Analysis

North America Liposome Drug Delivery Market Report Scope

Report Attribute Details
Market size in 2019 US$ 1,390.53 Million
Market Size by 2027 US$ 2,735.64 Million
Global CAGR (2019 - 2027) 9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product type
  • Liposomal Doxurubicin
  • Liposomal Paclitxel
  • Liposomal Amphotericin B
By Technology
  • Stealth Liposome Technology
  • Non PEGylated Liposome Technology
  • Depofoam Liposome technology
  • Lysolipid thermally Sensitive Liposome Technology
By Application
  • Fungal Diseases
  • Cancer Therapy
  • Pain management
  • Viral Vaccine
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Takeda pharmaceutical company
  • Novartis AG
  • Ipsen pharma
  • Celsion Inc
  • Luye pharma group
    		•